CorMedix CRMD Deferred Tax Assets Section One Seventy Four Capitalization
Deferred Tax Assets Section One Seventy Four Capitalization at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept crmd:DeferredTaxAssetsSectionOneSeventyFourCapitalization.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's deferred tax assets section one seventy four capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's deferred tax assets section one seventy four capitalization?
- CorMedix (CRMD) reported deferred tax assets section one seventy four capitalization of $5.16M in Q4 2024.
- What does deferred tax assets section one seventy four capitalization mean?
- This metric represents the deferred tax asset created by the mandatory capitalization and amortization of research and experimental expenditures under specific tax code provisions. It reflects the future tax deductions available as these R&D costs are amortized over time. It is a critical metric for biopharmaceutical companies to track the tax impact of their R&D investment strategy.